The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemia. - Connerty P; Colgan JN; El-Najjar F; Henry E; Xie J; Idais D; Gentile C; Mao J; Dolman MEM; Marshall GM; Lock RB (British journal of haematology, 2026)